Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Recruiting
1,152 enrolled
HELIOPREDICT
Recruiting
700 enrolled
ctDNA for Risk Stratification in Melanoma
Active not recruiting
296 enrolled
SHERLOCK
Recruiting
7,000 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Completed
25 enrolled 13 charts
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Completed
24 enrolled
COSMIC
Recruiting
2,000 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Active not recruiting
1,122 enrolled
IMMUMELA
Completed
217 enrolled
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Completed
14 enrolled
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Not yet recruiting
40 enrolled
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Recruiting
12,000 enrolled
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
Active not recruiting
126 enrolled
FIBIOME
Not yet recruiting
60 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
Active not recruiting
12 enrolled
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Recruiting
1,000 enrolled
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Active not recruiting
72 enrolled
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Recruiting
100 enrolled
SJFAMILY
Recruiting
1,500 enrolled
EVpredict
Not yet recruiting
378 enrolled
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
Completed
5 enrolled
IMPACT
Recruiting
80 enrolled
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Recruiting
30 enrolled
iCaRe2
Recruiting
999,999 enrolled
COPERGRAM1
Not yet recruiting
40 enrolled
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
Recruiting
24 enrolled
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Active not recruiting
6,000 enrolled
SPECIAL
Active not recruiting
14 enrolled
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
Completed
94 enrolled 8 charts
ICI-PICK
Completed
98 enrolled
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Recruiting
500 enrolled
IMM
Recruiting
221 enrolled
MELA_2025
Recruiting
25 enrolled
ROTATE
Not yet recruiting
20 enrolled
Mesur
Recruiting
300 enrolled
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Recruiting
20 enrolled
Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker
Recruiting
7,500 enrolled
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
Recruiting
200 enrolled
LIBERATE
Recruiting
2,500 enrolled
DISSEMELA
Completed
226 enrolled
Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques
Completed
73 enrolled
MELpreserv
Recruiting
80 enrolled
Molecular Analysis of Childhood and Adolescent Melanocytic Lesions
Recruiting
500 enrolled
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Recruiting
125 enrolled
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
Recruiting
300 enrolled
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Active not recruiting
19 enrolled